Live
- Shahid Kapoor’s ‘Ashwatthama’ kept on hold due to budget constraints
- ‘Drinker Sai’ teaser: Attracts youth
- Netflix Outage in India and US Ahead of Tyson vs Paul Match
- Police Intensify Investigation into Lagacharla Attack on Officers; Eight More Detained
- Google Docs Introduces AI-Powered Clip Art Generator with Gemini
- LIC sets up stall at India Int’l Trade Fair
- Celebrating journalism and its role in society
- Supporting emotional well-being in children
- Govt plans 1 mn sq km oil exploration by 2030
- Empowering the future through quality education
Suven Life secures 4 new patents
City-based Suven Life Sciences on Friday said it had secured four new patents from four different geographies for a drug used in the treatment of neuro-degenerative diseases.
Hyderabad: City-based Suven Life Sciences on Friday said it had secured four new patents from four different geographies for a drug used in the treatment of neuro-degenerative diseases.
“The grant of one product patent from Eurasia, one from Europe, one from Israel and one from Macau correspond to the New Chemical Entities for the treatment of disorders associated with neurodegenerative diseases,” Suven Life said in a release. The patents are valid till 2030.
“We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally,” said Venkat Jasti, CEO, Suven Life. With these new patents, Suven has 15 granted patents from Eurasia, 18 from Europe.
These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts. Products out of these inventions may be out-licensed at various phases of clinical development like at Phase-I or Phase-II.
